193 related articles for article (PubMed ID: 16582687)
1. Crystal-induced arthropathies: recent investigative advances.
Ellman MH; Becker MA
Curr Opin Rheumatol; 2006 May; 18(3):249-55. PubMed ID: 16582687
[TBL] [Abstract][Full Text] [Related]
2. Control of renal uric acid excretion and gout.
Taniguchi A; Kamatani N
Curr Opin Rheumatol; 2008 Mar; 20(2):192-7. PubMed ID: 18349750
[TBL] [Abstract][Full Text] [Related]
3. [Historical review of gout and hyperuricemia investigations].
Nakamura T
Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506
[TBL] [Abstract][Full Text] [Related]
4. Hyperuricemia, gout and the kidney.
Gibson T
Curr Opin Rheumatol; 2012 Mar; 24(2):127-31. PubMed ID: 22157498
[TBL] [Abstract][Full Text] [Related]
5. Genetics and experimental models of crystal-induced arthritis. Lessons learned from mice and men: is it crystal clear?
Reginato AM; Olsen BR
Curr Opin Rheumatol; 2007 Mar; 19(2):134-45. PubMed ID: 17278928
[TBL] [Abstract][Full Text] [Related]
6. [Primary hyperuricemia due to decreased renal uric acid excretion].
Yamauchi T; Ueda T
Nihon Rinsho; 2008 Apr; 66(4):679-81. PubMed ID: 18409514
[TBL] [Abstract][Full Text] [Related]
7. Hereditary nephropathy associated with hyperuricemia and gout.
Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
[TBL] [Abstract][Full Text] [Related]
8. Genetic factors associated with gout and hyperuricemia.
Bleyer AJ; Hart TC
Adv Chronic Kidney Dis; 2006 Apr; 13(2):124-30. PubMed ID: 16580613
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout).
Becker MA
Rheum Dis Clin North Am; 1988 Aug; 14(2):377-94. PubMed ID: 3051156
[TBL] [Abstract][Full Text] [Related]
10. The interplay between diet, urate transporters and the risk for gout and hyperuricemia: current and future directions.
Torralba KD; De Jesus E; Rachabattula S
Int J Rheum Dis; 2012 Dec; 15(6):499-506. PubMed ID: 23253231
[TBL] [Abstract][Full Text] [Related]
11. Crystal-associated arthritis in the elderly.
Wise CM
Rheum Dis Clin North Am; 2007 Feb; 33(1):33-55. PubMed ID: 17367691
[TBL] [Abstract][Full Text] [Related]
12. Advances in the management of gout and hyperuricaemia.
Hoskison TK; Wortmann RL
Scand J Rheumatol; 2006; 35(4):251-60. PubMed ID: 16882587
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hyperuricemia, gout and other crystalline arthritidies.
Lioté F
Reumatismo; 2012 Jan; 63(4):276-83. PubMed ID: 22303534
[TBL] [Abstract][Full Text] [Related]
14. Familial nephropathy associated with hyperuricemia in Spain: our experience with 3 families harbouring a UMOD mutation.
Puig JG; Prior C; Martínez-Ara J; Torres RJ
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1295-300. PubMed ID: 17065110
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia, gout and the metabolic syndrome.
Puig JG; Martínez MA
Curr Opin Rheumatol; 2008 Mar; 20(2):187-91. PubMed ID: 18349749
[TBL] [Abstract][Full Text] [Related]
16. The role of hyperuricemia in vascular disorders.
Edwards NL
Curr Opin Rheumatol; 2009 Mar; 21(2):132-7. PubMed ID: 19339923
[TBL] [Abstract][Full Text] [Related]
17. The kidney in hyperuricemia and gout.
Mount DB
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):216-23. PubMed ID: 23318701
[TBL] [Abstract][Full Text] [Related]
18. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout.
Dalbeth N; Merriman T
Rheumatology (Oxford); 2009 Mar; 48(3):222-6. PubMed ID: 19109320
[TBL] [Abstract][Full Text] [Related]
19. [Tophaceous gout in plurimetabolic syndrome].
Iannello S; Cavaliere G; Ferro G; Giuffrì MV; Impellizzieri D; Incognito C; Lizzio G; Neri S; Rapisarda A; Belfiore F
Minerva Med; 1998; 89(11-12):419-37. PubMed ID: 10212666
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenesis, diagnostics and therapy of gout].
Zurek M
Vnitr Lek; 2006; 52(7-8):736-41. PubMed ID: 16967617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
